Home > Quotes > MDGN

Medgenics, Inc. Stock Quote & Summary Data

Get MDGN Alerts
*Delayed - data as of Sep. 17, 2014 12:14 ET  -  Find a broker to begin trading MDGN now
Exchange: AMEX
Industry: Health Care
Community Rating:
View:    MDGN Real Time
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
1 Year Target: 15
Today's High/Low:  / 
Share Volume:
90 Day Avg. Daily Volume This is the average share volume for the past 50 trading days, for NASDAQ stocks and 90 trading days for Non-NASDAQ stocks. This field allows you to compare today's trading to the average daily volume. 34,688
Previous Close: $ 5.69
52 Week High /Low: $ 9 / $ 4.50
Market cap “Market Capitalization” is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. “Market Capitalization” is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements. $ 106,249,747
P/E Ratio: NE
Forward P/E(1y) A widely used stock evaluation measure. For a security, the Price/Earnings Ratio is given by dividing the Last Sale Price by the Average EPS (Earnings Per Share) Estimate for the specified fiscal time period. The forward P/E refers to the value for the next full year. NE
Earnings Per Share (EPS) The EPS listed on our infoquote and Summary Quote page is "12-mos Rolling". EPS represents the portion of a company's profit allocated to each outstanding share of common stock. Net income (reported or estimated) for a period of time is divided by the total number of shares outstanding (TSO) during that period; See growth rate measures for EPS. Our vendor's methodology for the EPS on the infoquote and Summary Quote pages follows the EPS used by the majority of the analysts following the stock, in many cases this is EBITDA EPS. $ -1.12
Annualized dividend N/A
Ex Dividend Date N/A
Dividend Payment Date N/A
Current Yield 0 %
Beta 0.04

Intraday Chart

Company Description (as filed with the SEC)

We are a medical technology and therapeutics company developing an innovative and proprietary platform technology offering what we believe to be a novel approach for the $50 billion orphan and rare diseases therapeutics market. Our Biopump Platform Technology converts a small piece of the patient’s own dermal skin tissue into a protein- and/or peptide-producing “Biopump” to continuously produce and deliver therapeutic proteins and/or peptides, and—when implanted under the patient’s skin—has the potential to deliver several months of protein/peptide therapy from a single procedure without the need for a series of frequent injections.  ... More ...  

News for MDGN

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?